•Big deals - $150M upfront, $1+B total
•Early deals – discovery platforms, preclinical compounds
•Clinical stage deals – Phase 1 thru Phase 3
•Territorial deals – China, Japan, US, Europe
•Technology deals
•Company acquisitions
•Profit sharing
•Co-development, Co-promotion
•University licenses
Recent Press Releases
WE DO DEALS
Some 75 and counting with many more term sheets, giving advice or leading negotiations.